Unaudited Results and cash dividend declaration for the six months ended December 2023 -- 1 of 72 -- 2 Performance overview Normalised operating profit +13% to R5 622m New business +28% to R14 197m Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Vitality Health Vitality Life USA Headline earnings +0% to R3 260m Normalised headline earnings +11% to R3 320m -- 2 of 72 -- 3 Navigating a complex backdrop 1 Sources: StatsSA, Statista, Office for National Statistics, US Bureau of Labor Statistics 2 Source: Bank of International Settlements Slowing inflation globally High interest rates Market outlook -2% 0% 2% 4% 6% 8% 10% 12% Jun-20 Oct-20 Feb-21 Jun-21 Oct-21 Feb-22 Jun-22 Oct-22 Feb-23 Jun-23 Oct-23 United States South Africa China United Kingdom Inflation rate by market1 Central bank policy rates2 0% 1% 2% 3% 4% 5% 6% 7% 8% 9% Jul-20 Oct-20 Jan-21 Apr-21 Jul-21 Oct-21 Jan-22 Apr-22 Jul-22 Oct-22 Jan-23 Apr-23 Jul-23 Oct-23 South Africa United Kingdom China United States South Africa • NHI bill has noble aims but creates uncertainty • Election permutations create uncertainty • Widespread power cuts have lessened • Building a perfect composite model, number 1 in every industry, along with supporting universal health coverage for all in South Africa United Kingdom • NHS challenges persist • High services price inflation continues to keep core inflation elevated • Building a new generation life and health insurer, particularly on the back of a complex NHS environment for the latter China • Relationship with the West remains strained • GDP growth is anticipated to remain below its 5% target • Economy is still struggling with deflationary pressures, keeping inflation far below its 3% target • Scaling Ping An Health Insurance in a complex Chinese market United States • Economic growth expected to slow in 2024 due to increased unemployment and fading post-pandemic tailwinds • Polarised elections raise economic uncertainty • Globalising our unique assets -- 3 of 72 -- 4 Well positioned for growth in the micro-environment Nature of risk Technology Social responsibility Demographic • Risk due to modifiable behaviours: 37% of healthcare expenses are due to modifiable behaviours • Causality of behaviour change: mortality, sickness and healthcare costs are significantly impacted by behaviour change. This impact is universal; it holds across age, gender, and health status; and is elastic - so even more significant for people who are older and sicker Nature of risk Demographic Technology Social responsibility • Ageing populations impact on healthcare: there is a corresponding rise in the incidence of chronic diseases as populations age, leading to a surge in healthcare expenses. Ageing demographics also contribute to a growing demand for long-term care services, further straining financial resources • Heightened obesity levels: obesity rates are increasing and the impact on healthcare costs is substantial • Artificial intelligence and machine learning advances: new tools are revolutionising diagnostics, treatment planning, and patient care • Benefits and costs of drug innovations: rapid advances in areas like precision medicine, targeted therapies and advanced pharmaceuticals like GLP-1s bring promising breakthroughs, yet the costs associated contribute to the overall financial burden on healthcare systems • Stakeholder needs are more widely defined: businesses face pressure to create value for all stakeholders through their products, services and client journeys • Evolution of value-based care: accelerated pressure on stakeholders to improve quality of care and decrease costs, through a patient-centric approach This requires a deep understanding of risk and how to manage it This requires preventative measures, interventions and disease management programmes to improve population health This requires sophisticated analytics to deliver hyper-personalised solutions This requires a shared-value business model -- 4 of 72 -- 5 Period under review 1 2 3 Strong financial performance with robust operating profit growth, good cash generation and capital resilience A smooth transition to IFRS 17 accounting standard A focused approach to create growth platforms by scaling the Bank, evolving the Vitality Shared-value model and streamlining New initiatives to embed significant growth potential into the Group Ensuring Discovery SA, Vitality UK, and Vitality Global, and their underlying businesses, are market leaders and performing optimally 4 -- 5 of 72 -- 6 Growth and performance Operating profit New business -- 6 of 72 -- 7 Strong operating performance Operating profit +13% R5 622m New business2 +28% R14 197m Non-insurance income +15% R2 942m ZARm Health 1 874 +7% 6 835 +52% 592 +3% Life – Individual 2 128 +12% 1 444 +7% Life – Group 139 -42% 75 -42% Invest 620 +11% 1 629 +8% Insure 20 +150% 666 +8% Bank -339 -15% 933 +32% Other SA1 -87 +12% 451 -13% SA composite 4 355 +9% 11 100 +29% 1 525 +19% VitalityHealth 527 -20% 1 135 +28% VitalityLife 390 +97% 935 +17% VitalityInvest -57 -48% Other initiatives and central costs -48 +85% UK composite 812 +13% 2 070 +22% Vitality Network 296 +49% 942 +25% VHI – Ping An Health Insurance 344 +305% 1 0273 +28% VHI – Other and central costs -185 +928% 475 -8% VG composite 455 +71% 1 027 +28% 1 417 +11% 1 Vitality, Other SA Initiatives and Group initiatives and central costs 3 PAHI own licence 2 Excl products in run down New business boosted by successful take-on of Sasolmed Strong earnings and improving new business margins Declined off prior period’s exceptional performance Benefited from higher market levels Increased demand from backlogs in NHS drove higher new business, along with an increase in claims experience Earnings increased from higher interest rates and once- off variances, VNB margins under pressure Strong growth and margin expansion Excellent operating metrics, new business exceeded expectation Profit curtailed by two severe weather events Continued investment into VHI Achieved operational break-even on a monthly basis, excellent performance across all metrics -- 7 of 72 -- 8 - 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 H1 2003 H1 2004 H1 2005 H1 2006 H1 2007 H1 2008 H1 2009 H1 2010 H1 2011 H1 2012 H1 2013 H1 2014 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Significant operating profit and new business growth over time Operating profit New business IFRS 4 IFRS 17 0 1,000 2,000 3,000 4,000 5,000 6,000 H1 2003 H1 2004 H1 2005 H1 2006 H1 2007 H1 2008 H1 2009 H1 2010 H1 2011 H1 2012 H1 2013 H1 2014 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Rapid growth in IFRS 4 earnings historically, relatively flat on transition, and positioned for growth going forward Operating profit New business +13% +28% New business excluding Discovery Health +11% -- 8 of 72 -- 9 0% 20% 40% 60% 80% 100% FY19 H1 20 FY20 H1 21 FY21 H1 22 FY22 H1 23 FY23 H1 24 Group well capitalised with robust cash generation DHMS solvency (unaudited) 30.6% 1 Capital Adequacy Ratio 2 Comprehensive Solvency Ratio, definition set by China Banking and Insurance Regulatory Commission 3 Considers cash at centre, Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank 4 Centre cash + undrawn committed facilities 5 FY 2022 excludes life COVID claims net of financing FLR within target 14% 16% 18% 20% 22% 24% 26% 28% 30% FY 22 H1 23 FY 23 H1 24 0% CSM 50% CSM 100% CSM 28% 24% 20% 17% FLR Highly liquid across the Group Liquid assets across the Group3, Rm - 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 H1 21 FY21 H1 22 FY22 H1 23 FY23 H1 24 Strongly capitalised Dec 22 Cover Dec 23 Cover Life 1.8x 1.8x Insure 1.4x 1.5x VH 1.5x 1.4x VL 2.2x 2.3x Bank1 1.2x 1.3x PAHI2 2.7x 3.1x Strong cash conversion Group cash conversion5 COVID and investment in New 66% Sufficient centre liquidity Centre liquidity4, Rm - 500 1,000 1,500 2,000 2,500 3,000 H1 21 H1 22 H1 23 H1 24 R2.6bnR17.9bn -- 9 of 72 -- 10 Strong growth in Group Embedded Value Opening EV Value of new business Unwind of risk discount rate Non-economic experience variances and methodology & assumption changes Operational EV Economic experience variances and methodology & assumption changes Forex New Initiatives Other IFRS 17 Transition Impact Closing EV 12.1% Annualised RoEV R105 251m R98 176m R103 480m -- 10 of 72 -- 11 IFRS 17 performance H1 FY23 to H1 FY24 R million Actual Actual % H1 2024 H1 2023 Normalised profit from operations 5 622 4 973 +13% Forex losses/gains -40 28 1 DP finance lease impact -59 -73 Finance charges excl. 1DP finance lease -881 -778 Investment income and fair value gains on financial instruments 195 132 Other -72 -50 Profit before fair value gains on VL swaption 4 765 4 232 +13% Fair value gains on VL swaption - 391 Profit before tax 4 765 4 623 +3% Taxation -1 422 -1 385 Profit after tax 3 343 3 238 +3% Profit not attributable to ordinary shareholders -89 - 31 loss on impairment and derecognition of assets net of tax 6 69 Headline earnings 3 260 3 276 0% Amortisation of intangibles from business combinations, net of tax 45 39 Economic assumptions adjustment - VL - -311 Restructuring costs 15 - Normalised headline earnings 3 320 3 004 +11% The prior reporting period includes a considerable fair value gain from the swaption, which was realised towards the end of the previous financial year -- 11 of 72 -- 12 Dividend policy Previously communicated at FY23 announcement: Annual ordinary dividend is expected to be covered approximately 5 times by normalised headline earnings Interim ordinary dividends expected to be paid in the range of 30%-40% of the expected total annual ordinary dividend, with the remainder of the dividend to be paid as a final dividend The Group has declared its interim ordinary dividends for period at 65 cents per share -- 12 of 72 -- 13 Transition to IFRS 17 -- 13 of 72 -- 14 Recap of IFRS 17 key messages No change in underlying value nor underlying economics • No direct change to cash flows, underlying risk and reward of contracts. Tax cash flow impact expected to be immaterial • No impact on regulatory or economic solvency, capital position or capital management • Immaterial impact on Embedded Value • Ability to pay dividend unaffected as cash flows and solvency remain unchanged Accounting standard change that affects the timing of profit recognition, therefore affects transitional balance sheet 1 2 IFRS 4 IFRS 17 Duration Annual p rofit Discovery Life Vitality Life Group is approaching cross-over Value unchanged but reallocated IFRS 4 IFRS 17 0 1,000 2,000 3,000 4,000 5,000 6,000 H1 2003 H1 2005 H1 2007 H1 2009 H1 2011 H1 2013 H1 2015 H1 2017 H1 2019 H1 2021 H1 2023 Strong IFRS 4 profit growth -- 14 of 72 -- 15 Life 2 518 2 145 -15% Invest 592 561 -5% VitalityHealth 867 658 -24% VitalityLife 536 198 -63% Other 1 417 1 411 0% Total 5 930 4 973 -16% H1 2023 restated from IFRS 4 to IFRS 17 Reconciliation of comparative period from IFRS 4 to IFRS 17 Rm £10m (R204m) reduction in FinRe payments in the H1 2023 emerged as profit under IFRS 4. Under IFRS 17 this value would effectively have been reflected in previous reporting periods, which is included in the reported net asset value £18m (R373m) of premium indexation in the prior period due to higher rates of inflation, which emerged as profit under IFRS 4. Under IFRS 17, this value is presented in other comprehensive income (OCI), which will emerge as profit in the future Difference between IFRS 4 and IFRS 17 is volatile in the short-term IFRS 4 IFRS 17 % Life -3% -9% Invest -26% -18% VitalityHealth -111% -42% VitalityLife -22% -43% Other 1% 0% Total -12% -14% H2 2023 FY 2023 VitalityHealth’s FinRe impact increased to £22.1m (R450m) for FY 2023, widening the gap between IFRS 4 and IFRS 17 H1 2023 earnings IFRS 4 vs IFRS 17 for H2 and FY 2023 IFRS 4 leads to a significant level of volatility that is reduced under IFRS 17 through the use of CSM and OCI As at December 2023 the Group had R38.2bn of CSM net of reinsurance H1 2023 benefited from lapse gains recognised under IFRS 4 whilst deferred in CSM under IFRS 17. This difference narrowed materially over the full restated prior reporting year to 30 June 2023 as the business progresses towards cross-over Invest gap widens due to positive cash flow and lapse experience variances taken to CSM under IFRS 17 -- 15 of 72 -- 16 Business performance and Growth platforms Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health Vitality Health Vitality Life USA -- 16 of 72 -- 17 Discovery grows businesses organically Organic growth model Focused on streamlining New initiatives Growth platforms expected to drive material growth Investment in New % core operating profit 0% 5% 10% 15% 20% 25% H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 + 10% to 15% higher cash flow growth GROWTH PLATFORMS + 5% to 10% higher annual operating profit growth ESTABLISHED EMERGING NEW Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors CPI+5% CPI+30% -10% ESTABLISHED BUSINESSES GROWTH PLATFORMS -- 17 of 72 -- 18 The Vitality chassis has evolved -- 18 of 72 -- 19 Vitality’s rich and comprehensive dataset allows for a sophisticated understanding of behaviour and the impact on risk Health records Incentives Demographic Wellness & Behavioural Mortality & healthcare utilisation Clinical Financial Risk predictions Diagnoses & medication Pathology & radiology Episodes of care Incentives utilisation habits Response to rewards Incentive partner preferences Age Chronicity Gender Family status Location Socio-economic status Travel Smoking status Vitality age HealthyFoods Exercise & Device data Hospitalisations Population segmentation Healthcare claims & quality Audited mortality & causes Debt Retirement savings Transactions Property ownership Savings Data science Machine learning and AI Vitality engagement | 26.5m life-years Data from health checks and assessments, enrollment into Vitality programs such as healthy weight and smoking cessation Device data | 1.1bn events All step and heartrate data gathered by devices from the Vitality program Wellness Health utilisation | 48.7m life-years Claim lines, hospital admissions, benefit details, Demographic | 48.7m life-years Member information, e.g. age, gender, health-related test results, chronic conditions, and programs etc. Conditions | 11.7m life-years Chronic registrations, pathology results, health related test results Clinical Clinical and wellness data linked longitudinally Using data from 2008 until 2024 -- 19 of 72 -- 20 The effect of behaviour change exceeds expectations Physical activity has a significant impact on mortality and increases by age Physical activity has a significant impact on healthcare costs -29% -52% -59% 0 (base) Low Medium High -36% -38% -58% 0 (base) Low Medium High Relative mortality for the 45-65 age group Relative mortality for the 65+ age group Relative reduction for the 45-65 age group Relative reduction for the 65+ age group -16% -25% No Habit Strong poor habit Strong good habit -14% -29% No Habit Strong poor habit Strong good habit No habit Strong poor habit Strong good habit No habit Strong poor habit Strong good habit Effects of behaviour change increase with age and chronicity Young moderately healthy 30-year-old 10.2 56.7 43.5 53.7 Healthspan Sick years 10 46.7 Middle age unhealthy 50-year-old 10 .2 16.6 24.9 Healthspan Sick years 25.1 Advanced age unhealthy 70-year-old 4 14.6 6.1 10.1 Healthspan Sick years 11.6 +7% increase in healthspan +51% increase in healthspan +90% increase in healthspan 8.3 33.5 8.4 3 -- 20 of 72 -- 21 Vitality enhances the traditional value chain UNDERWRITING PREMIUMS CLAIMS AND EXITS TRADITIONAL VALUE CHAIN Underwriting Claims and Exits SHARED-VALUE VALUE CHAIN Dynamic Risk Assessment AI Recommender Incentivised Engagement Shared-value Pricing Value Propensity Δ Habit Curated partner intervention network Behaviour incentives Hyperbolic discounting Loss aversion Over optimism Premium archetypes Personalised mortality curves Fewer dimensions environment Vitality wellness data Devices + physical activity Mental wellbeing Behavioural Claims Nutrition data Clinical data repository U/W data Demographics More dimensions environment Full dimensions environment Exercise Healthy actions Ranks the top 3 Next Best Actions VALUE x PROPENSITY → HABIT Get your HbA1c Take 5k Steps 2x Gym Visit Get Flu Vaccine Heart Rate Workout Get a mammogram Visit your PCP Complete VHC Park Run Mental wellbeing assessment Colon cancer screening Visit your dentist Healthy actions HEALTHSPAN Effective years in perfect health SICK YEAR S Risk 1 LIFESPAN Risk 2 Risk 5 Risk 6 Risk 3 Ris k 4 SICK YEARS HABIT MORTALITY CURVES -- 21 of 72 -- 22 AI Recommender -- 22 of 72 -- 23 Hyper-personalised Next Best Actions, with personalised goals VALUE PROPENSITY HABIT Causal model built to estimate the effect of completing an NBA on downstream healthcare costs Ensemble Machine Learning model built to estimate the probability of a customer to complete an NBA Index built to quantify and classify a customer's consistency of completing an NBA Get your HbA1c Get Flu Vaccine Visit your PCP Complete VHC Get Flu Vaccine Get your HbA1c Visit your PCP Complete VHC Get your HbA1c Get Flu Vaccine Visit your PCP Complete VHC Weak Bad Strong Good Weak Good Strong Bad Take 5k Steps 2x Heart Rate Workout Gym Visit Park Run Strong Good Weak Good Strong Bad Weak Bad Heart Rate Workout Take 5k Steps 2x Gym Visit Park Run Take 5k Steps 2x Gym Visit Heart Rate Workout Park Run -- 23 of 72 -- 24 Personal Health Pathways | A hyper-personalised programme manifesting in a simple user experience with two rings Wearables/IoT Mobile Activity General Engagement Assessments Screenings Underwriting Data Data Dimensions Claims Hospital Experience Member Information Data Sources Personal Health Pathway Dynamic Risk Assessment Next Best Action Exercise Healthy actions VALUE PROPENSITY Mortality curves HEALTHSPAN Effective years in perfect health SICK YEARS Risk 1 LIFESPAN Risk 2 Risk 5 Risk 6 Risk 3 Risk 4 SICK YEARS Risk 1 Risk 2 Risk 5 Risk 6 Risk 3 Risk 4 Healthy actions Habit Applicable to: • Vitality Network • VHI • Discovery Health • Discovery Life • VitalityHealth • VitalityLife In future, Bank and Insure -- 24 of 72 -- 25 Life insurer | The impact is significant on all measures 12% higher VoNB 100% 104% 112% 90% 95% 100% 105% 110% 115% Traditional Insurer value Higher VoNB Customer value Bronze never pays more than traditional Lower premiums (PV premiums vs Traditional, over 20yrs) 15% more lives over 20 years 20 30 40 50 60 70 80 90 100 1 5 9 13 17 21 2529 Larger portfolio of lives covered Traditional 36% more engagement 25% 35% 45% 55% 65% 1 5 9 13 17 21 25 29 More health- engaged members Value drivers of Personal Health Pathways • Higher status transitions from unengaged to engaged • Lower lapses • Narrower risk differentiation within each status 0% 20% 40% 60% 80% 100% More rewards (Vitality rewards as % Vitality premiums) 18% more Vitality rewards 80 85 90 95 100 1 6 11 16 21 26 94% Lower premiums Reduced cost of cover Traditional Societal value Bronze 99% Silver 95% Gold 81% Platinum 81% Vitality-integrated products Vitality with Personal Health Pathways -- 25 of 72 -- 26 Health insurer | The impact is significant on all measures Distribution of clients by healthcare costs Impact of doing Next Best Action | Net savings to health funder Member base by different healthcare utilisation scores Healthcare utilisation score Higher Top 25% of clients within chronic cohorts with highest value x propensity to target with NBA At-risk or unhealthy clients Other 0% 20% 40% 60% 80% 100% 0% 25% 50% 75% 25% of members complete NBA 58% of potential saving Percentage completing NBA Percentage saving Distribution Lower Engagement Diabetes 0% 20% 40% 60% 80% 100% 0% 25% 51% 76% Hypertension Combined hypertension and diabetes 0% 20% 40% 60% 80% 100% 0% 25% 51% 76% Percentage completing NBA Percentage completing NBA 25% of members complete NBA 25% of members complete NBA 53% of potential saving 58% of potential saving -- 26 of 72 -- 27 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 27 of 72 -- 28 Discovery Bank Clients Deposits Operating result Revenue (NII + NIR) +42% +31% -15% +32% to 825k to R16.67bn to (R339m) to R933m H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 NII NIR H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Loss before NBAC NBAC Accounts Clients -40% to (R154m) Before NBAC Advances +20% to R5.75bn H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 -- 28 of 72 -- 29 New business acquisition costs driven by strong growth - 200 400 600 800 1 000 1 200 Jul-21 Oct-21 Jan-22 Apr-22 Jul-22 Oct-22 Jan-23 Apr-23 Jul-23 Oct-23 Average daily sales Source of new business New business acquisition costs New business product mix >1 000 54% 0% 10% 20% 30% 40% 50% 60% 0 1 2 3 4+ New business by number of Discovery products Average July 2023 – December 2023 Product mix of new business >40% Transaction Bundled accounts, Credit cards and Suites 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 Q2 FY24 Savings only Trans PAYT Trans Bundled Credit & Suite Average sales per business day Jul-21 Sep-21 Nov-21 Jan-22 Mar-22 May-22 Jul-22 Sep-22 Nov-22 Jan-23 Mar-23 May-23 Jul-23 Sep-23 Nov-23 Average +10% Average -10% Average New business acquisition costs per new client -- 29 of 72 -- 30 Strong NIR growth Spend is normalised for days in month. Total net NIR Increasing NIR per client by duration Record-high monthly banking activity H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 H1 2024 38% CAGR 0% 50% 100% 150% 200% 250% 1 2 3 4 5 6 7 8 9 10 11 12 NIR per new client by months on book (indexed to first month after joining) Months on book Monthly spend and payment volumes Jul-21 Sep-21 Nov-21 Jan-22 Mar-22 May-22 Jul-22 Sep-22 Nov-22 Jan-23 Mar-23 May-23 Jul-23 Sep-23 Nov-23 Payment volumes Normalised Spend 65% CAGR 58% CAGR Rm -- 30 of 72 -- 31 Strong NIR growth driven by Banking capabilities Make payment Discover View class schedules Confirm booking VITALITY FITNESS Pay using Vitality Pay, Discovery Miles or a free credit Confirm your spot at the class in a few taps Go through the facility’s class schedule to find a suitable slot Choose from >400 facilities in South Africa VITALITY TRAVEL Make payment Discover View flights Select flight Pay using Discovery Miles or a Discovery bank account Select your flight and confirm flight details Go through the various flight options with discounts applied Select travel routes and dates Vitality Travel utilisation stats as at December 2023 >1.4m cumulative flights booked since launch 2 338 members flying per day with Vitality Travel >170k cumulative lounge visits since launch -- 31 of 72 -- 32 High-quality credit growth strategy supported by the Shared-value model and integration Total NII Credit growth strategy Non-performing loans Shared-value impact and value of integration 0% 25% 50% 75% 100% Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 Q2 FY24 ELR LR MR HR VHR 0% 20% 40% 60% 80% 100% ELR LR MR HR VHR -79% Approval rate by credit risk (indexed to exceptional low risk) New business risk distribution Credit loss ratio by Vitality Money status Risk distribution by DSY vs non-DSY clients 0% 10% 20% 30% 40% E ELR LR MR HR VHR Discovery Non-Discovery -2% 2% 6% 10% J-22 M-22 M-22 J-22 S-22 N-22 J-23 M-23 M-23 J-23 S-23 N-23 Blue Bronze Silver Gold Diamond 0% 1% 2% 3% 4% 5% 6% 7% 8% 9% 10% 11% 12% 13% 14% A-21 O-21 D-21 F-22 A-22 J-22 A-22 O-22 D-22 F-23 A-23 J-23 A-23 O-23 D-23 Stage 3 (NPL) Stage 3 TTC average Stage 3 average big four banks Stage 3 advances ELR: Exceptional low risk; LR: Low risk; MR: Medium risk; HR: High risk; VHR: Very high risk H1 2021 H2 2021 H1 2022 H2 2022 H1 2023 H2 2023 H1 2024 45% CAGR Rm -- 32 of 72 -- 33 Discovery Bank home loans market launch Home loans mispricing is an opportunity to create value <-2.5% -2% --1.5% -1% -0.5% 0% 0.5% 1% 1.5% 2% 2.5% >3% 60% Of Discovery Bank clients would get an interest rate reduction Mispriced Discovery Bank clients R280bnHome loan balances held by Discovery Bank clients R1 400bn Home loan balances held by South Africans Interest rate saving calculated assuming an average interest rate of prime The Discovery Bank Home Loan New home loans, switch or refinance Dynamically reduce interest rate by up to 1% Up to 100% financing with personalised interest rates Up to 30-year term Up to three co- applicants -- 33 of 72 -- 34 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 34 of 72 -- 35 1993 1996 1999 2002 2005 2008 2011 2014 2017 2020 2023 Non Scheme Products Restricted Schemes DHMS Jan-18 Jun-18 Nov-18 Apr-19 Sep-19 Feb-20 Jul-20 Dec-20 May-21 Oct-21 Mar-22 Aug-22 Jan-23 Jun-23 Nov-23 Flexicare Gap Cover Healthy Company H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Discovery Health Operating profit & new business include Vitality Health International Africa Operating profit New business Non-scheme growth Membership +7% +52% >3.8m to R1 874m to R6 835m Lives under administration Lives >340k Revenue to R722m H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Sasolmed closed scheme +7% +17% -- 35 of 72 -- 36 Discovery Health Medical Scheme: continued excellent performance in a complex environment Membership and market share as at June 2023 Plan changes exclude impact of plan closures Membership Customer satisfaction Solvency DHMS Rest of Industry Others 57.8% market share 0% 2% 4% 6% 8% 10% 2019 2020 2021 2022 2023 Low proportions of members change plans, with more members upgrading than downgrading: Lapses continue to remain stable R27.1bn 30.6% AAA unaudited reserves unaudited solvency credit rating 0% 5% 10% 15% 20% 25% 30% 35% 40% - 5 10 15 20 25 30 35 2019 2020 2021 2022 2023 Reserve Actual Solvency Required Solvency R billion 0% 1% 2% 3% 2019-20 2020-21 2021-22 2022-23 2023-24 Upgrades Downgrades 96% no plan changes -- 36 of 72 -- 37 Significant value from introducing Personal Health Pathways Chronicity Ability to identify the most valuable clients to target Significant uplift Chronic ratios continue to increase 24% 26% 26% 27% 28% 22% 23% 24% 25% 26% 27% 28% 29% 2019 2020 2021 2022 2023 Members or clients living with chronic disease are ~4X more expensive than those without chronic disease Members living with diabetes Members living with hypertension Combined effect Base cost 25% complete NBA 50% complete NBA Cost savings where Next Best Action (NBA) is followed 58% 78% 53% 79% 58% 80% Healthcare utilisation score Higher Top 25% of clients within chronic cohorts with highest value x propensity to target with NBA At-risk or unhealthy clients Other Distribution Lower -- 37 of 72 -- 38 A change to Section 33 is required to enable private sector collaboration “33. Once National Health Insurance has been fully implemented as determined by the Minister through regulations in the Gazette, medical schemes may only offer complementary cover to services not reimbursable by the Fund” Discovery’s position: NHI is not workable without private sector collaboration R200bn Additional funding required p.a, as indicated by the National Department of Health for narrowed benefit package Healthcare funding available per person remains constrained (ZAR) 31% increase in personal income tax or; 6.5% increase in VAT (from 15% to 21.5%) or; 10x increase in payroll tax (current UIF contributions). 407 714 Current funding for uncovered lives With additional R200bn 2332 714 Current private medical schemes Current NHI proposal – 69% Public sector Private sector NHI Status quo is unsustainable – universal healthcare is crucial -- 38 of 72 -- 39 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 39 of 72 -- 40 IFRS 17 Discovery Life Normalised operating profit New business Strong capital and liquidity +6% +2% to R2 267m to R1 519m Individual life: +12% SCR coverage Liquidity coverage 2023 2023 180% R4 911m 1 X ILT 125% SCR Target Individual life : +7% 12 months to December 2023 Maintained leading market share Strong cashflow generation Life and Invest cash flow in excess of 35% of net of tax normalised earnings H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Individual Group H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Individual Group Premium and Fees Claims Operational costs Cashflows from existing New business strain Cashflows before FinRe Net Finre Net Cashflow R771m R2 841m R10 427m R1 093m 26.6% 2022 2023 27.5% Discovery Life Market Share: +0.90% growth vs prior year, 1st and growing across IFA and Tied channels, negligible current share of bancassurance NMG Market Share survey: Total Affluent Protection Market 2023 -- 40 of 72 -- 41 Largely offsetting Discovery Life Ltd variances (Rm): Robust EV growth with positive operating variances Life and Invest Positive non-economic operating variances Growth in Embedded Value Jun-23 Dec-23 R41 138m R42 863m 12% RoEV R81m 0% 20% 40% 60% 80% 100% 120% Mortality Morbidity Lapses H1 2023 H1 2024 Individual life Premium and fee income gain driven by positive integration experience Policy alterations was a significant negative variance and worsened from prior period 15.3% constant economics Improving claims experience, with favourable mortality largely offsetting elevated morbidity Mortality and morbidity Persistency Premium and fee income Policy alterations Other Total Non-Economic Economic Total -- 41 of 72 -- 42 Margin improvement and generating significant customer value Significant improvement in VNB margin Individual life: 5.6% (IRR: 21.5%) VNB Margin (%) Increase in margin driven by: • Strong new business volumes in Individual Life • Improved business mix • Efficient expense management • Negative economic impact Jun-23 Economic Unit Expenses Business Mix Dec-23 2.5% 4.3% Individual life: 3.2% (IRR: 19.2%) Superior returns driven by Shared-value model c70% of value from behavioural uplift returned to policyholder VNB per unit of premium*: from Shared- value model 1.8x times *Based on June 2023 data and long-term interest rate view -- 42 of 72 -- 43 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 43 of 72 -- 44 IFRS 17 Discovery Invest Normalised operating profit New business Assets under administration +11% +8% +11% to R620m to R1 629m to R145bn Dec-17 Jul-18 Feb-19 Sep-19 Apr-20 Nov-20 Jun-21 Jan-22 Aug-22 Mar-23 Oct-23 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Cogence Full executive team in place On track for R16bn AUM in short-term Fully integrated Aladdin WealthTM technology with Vitality Healthy Futures -- 44 of 72 -- 45 Discovery Insure Discovery Life Discovery Invest Discovery Bank Discovery Health -- 45 of 72 -- 46 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Discovery Insure Gross written premium Gross new business Normalised operating profit Vehicles insured +9% +8% -92% +1% to R2.8bn to R666m to R2m to 291 194 1 Personal lines figures only 2 Figures excluding VAT 3 Normalised operating profit includes Personal lines but excludes Cambridge Mobile Telematics (CMT), Sigfox and Bi-ME H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 -- 46 of 72 -- 47 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 H1 2024 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 H1 2024 Average claims cost increase Average in-force premium increase 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 1 2 3 4 5 6 7 8 9 10 11 12 13 Duration on book Good Average Bad Loss Ratio Target loss ratio Pre-CAT loss ratio Actual loss ratio Insure well positioned to achieve target margin Operating margin set back due to loss of pricing power during COVID and extreme weather impacts Vitality allows for a unique business model Best drivers receive value and are less likely to lapse 17% 10% 9% 7% 0% 0%-5% 5%-10% 10%-15% 15%-20% 20%-25% Proportion of good drivers increases over time resulting in lower loss ratios Gauteng hailstorm in November 2023 was the worst in Insure’s history R130.7m net impact of extreme weather events set margin recovery back Distribution of drivers in 2023 relative to duration of in-force policies Average premium increases reflect repricing strategies after COVID impact 58% lower lapse rate for same premium increase Lapse rate by VD status and premium increases COVID-19 Average increase + 3% Good drivers have a 36% lower loss ratio than bad drivers Average increase - 3% -- 47 of 72 -- 48 Vitality Health Vitality Life -- 48 of 72 -- 49 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 IFRS 17 UK Composite Normalised operating profit Earned premiums New business Lives covered -2% +11% +6% +5% to £34.7m to £536m to £88.3m to 1.8m lives H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 GBP millions GBP millions GBP millions +13% to R812m +27% to R12.6bn +22% to R2.1bn H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Both VH and VL earnings impacted by specific aspects in the transition from IFRS 4 to IFRS 17 -- 49 of 72 -- 50 IFRS 17 VitalityHealth Normalised operating profit Earned premiums New business Lives covered -30% +11% +11% +10% to £22.5m to £339.4m to £48.4m to 989k lives GBP millions GBP millions -20% to R527m +27% to R8bn +28% to R1.1bn GBP millions H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Impact of increased claims spend -- 50 of 72 -- 51 Dynamics of healthcare in the UK NHS Digital: Referral to Treatment Waiting Times UK Health Accounts 2022 Challenges in accessing treatment Material gearing effect for private healthcare 0 1 2 3 4 5 6 7 8 9 Jan-13 Nov-13 Sep-14 Jul-15 May-16 Mar-17 Jan-18 Nov-18 Sep-19 Jul-20 May-21 Mar-22 Jan-23 Nov-23 NHS waiting list (millions) 7.6m National Health System (NHS) waiting list 6.7 233 0 50 100 150 200 250 Private heathcare expenditure NHS budget Healthcare expenditure (£bn) c35x -- 51 of 72 -- 52 NHS backlogs resulting in increased utilisation with a shift to primary care Shift to primary care Substantially increasing benefit utilisation Pricing actions implemented Impacting overall claims experience +18% -9% +7% Claimants per 1,000 lives Cost per claim Claims PLPM 2015 2016 2017 2018 2019 2020 2021 2022 2023 Optical, Dental and Hearing Physiotherapy Talking Therapies Vitality GP 2019 2020 2021 2022 2023 In-Hospital Consultations Consultant Procedures Radiology Pathology Vitality GP CBT Physiotherapy 62% Claims attributable to primary care Change in claims experience (2022 vs 2023) Vitality GP +322% CBT +200% Optical, dental & hearing +113% Claims per 1 000 lives >£25m impact Claims increase vs average written premium by renewal cohort Jul-22 Sep-22 Nov-22 Jan-23 Mar-23 May-23 Jul-23 Sep-23 Nov-23 Jan-24 YoY increase in claims PLPM YoY increase in 3m average premiums -- 52 of 72 -- 53 Excellent quality of the business positions it well for growth 1. LaingBuisson Health Cover Report (18th Edition) Strong growth Resilient retention rates Unique digital capabilities and industry recognition Individual and SME lapse rates Digital assets 4.9 4.3 Vitality GP app rating Vitality Trustpilot score -14% 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 3rd largest health insurer1 -- 53 of 72 -- 54 IFRS 17 VitalityLife Normalised operating profit Earned premiums New business Lives covered +71% +10% +2% +6% to £16.6m to £196.7m to £39.9m to 782k lives GBP millions GBP millions GBP millions +97% to R390m +26% to R4.6bn +17% to R935m H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Higher interest income and once-off variances -- 54 of 72 -- 55 Embedding Shared-value in the PAC book Causal impact of behaviour change Behavioural-based valuation model Shared-value modelling on PAC book £4.8m Once-off uplift in value Timing difference due to Prudential FY end at December Prudential adopted causal inference and habit formation Shared-value assumption changes Expect positive variances in future as engagement increases and habit formation continues Isolating the impact of physical activity on mortality after adjusting for confounding factors Death (𝑡2) (Outcome) Physical activity points (𝑡1) (Treatment) Age (𝑡0) Vitality Status (𝑡0) Duration on Vitality Total Claims (𝑡0) RUB (𝑡0) Socio- economic score (𝑡0) Chronic Count (𝑡0) PA Points per Week (𝑡0) Health Status Demographic Physical activity Differential assumptions and transitions Mortality, morbidity, lapses Bronze Silver Gold Blue Transitions No activity Bad / Medium activity Good activity 6-week habit Weak habit Weak bad Weak good Strong bad Strong good Strong habit Create habit Increase activity level Increase activity level Create habit 1. 2. 3. 4. -- 55 of 72 -- 56 Positive lapse and claims experience, and offsetting impacts from high interest rates Positive experience variances High long-term interest rates Margins negatively impacted Strong indexation results Aug-2022 Sep-2022 Oct-2022 Nov-2022 Dec-2022 Jan-2023 Feb-2023 Mar-2023 Apr-2023 May-2023 Jun-2023 VNB margin (%) 95.5% UK 50-year swap rate history1 Indexation continuation upon policy anniversary 0% 1% 2% 3% 4% 5% 2019 Jan 2020 Jan 2021 Jan 2022 Jan 2023 Jan 2024 Jan 1. MarketWatch 2.Office for National Statistics: CPI EV experience variances (£m) £13.8m indexation benefit to OCI Measures being implemented • Targeted growth in profitable segments • Release of expense efficiencies • Balance sheet optimisation Consumer Price Inflation2 0% 4% 8% 12% Jan-19 Jun-19 Nov-19 Apr-20 Sep-20 Feb-21 Jul-21 Dec-21 May-22 Oct-22 Mar-23 Aug-23 2.09% IRR above RFR 4.8 1.8 3.0 9.6 Premium Income Lapses & CFIs Mortality and Morbidity Total -- 56 of 72 -- 57 USA -- 57 of 72 -- 58 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Vitality Global Vitality Global Operating result Strong underlying growth, driven by deepened partner relationships, broadening the reach of Vitality assets and capabilities Vitality Network Vitality Health International +55% to $24.4m +71% to R455m USA HEALTH -- 58 of 72 -- 59 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Vitality Network Integrated API by insurance partners Revenue Insurance partners membership Operating profit +16% to $806.7m +25% to R15.1bn +16% to $50.3m +25% to R941.5m +37% to $15.8m +49% to R295.8m +28% to 4.3m H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 -- 59 of 72 -- 60 Key strategic focus areas 1 Revenue growth through deepening of existing insurance partnerships and targeted pursuit of new insurance partnerships, as well as starting to participate in emerging profits 2 Unlock geared profits through operational efficiency generated from scaling, South Africa based back office and offshore development centre 3 Evolving Vitality products driving greater value 40 25 16 10 4 5 % Revenue (in USD) Emphasis on expansion within the US Market TATA AIA India membership has grown by 5.5x over the last calendar year +16% Revenue growth from December ‘22 +37% Profit growth from December ‘22 Revenue Expenses Significant mortality improvements across markets H1FY20 H1FY21 H1FY22 H1FY23 H1FY24 35.6m 33.6m 42.2m 43.5m 50.3m 34.5m 32.0m 33.5m 25.3m 31.2m -- 60 of 72 -- 61 USA +96% to $9.2m +125% to R171m HEALTH VHI - Other VHI – PAHI Including PAHI equity earnings Vitality Health International Vitality Health International Operating result H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Driven largely by growth in PAHI Vitality USA continues to accelerate its development of its technology platform, including the new Personal Health Pathways product, with a robust pipeline of prospective sales and strong growth in the rate of successful sales. PAHI continues to be a resilient performer with the business beginning to see a return on the investments made in diversifying its distribution channels with 28% growth in new business on PAHI licence for the period, despite a reduction in PAL agency force. Total written premiums increased 14%, growing 10% faster than the market average. Continued strong progress in build-out of four cloud-native SaaS solutions, with three key products already at deployment stage. Increased sales traction and pipeline emerging in AIA markets and with third party-clients in the region. Revenue continues to be under pressure post the conclusion of Covid government contracts. The business continues to pursue opportunities to diversify its footprint both geographically and across client segments, and is successfully implementing a best- in-class data science platform with AI-driven personalised health recommendations for Discovery Health SA, and similar implementations for Vitality UK and Vitality US. -- 61 of 72 -- 62 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 PAHI licence Reinsurance H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Investment income and gains Profit before investment income and gains to RMB0.6bn (RMB140m DSY’s share) 1 100% of PAHI PAHI’s operating results pre-tax Discovery’s operating result after tax PAHI licence new business1 Written premium1 +126% +305% +28% +14% to R1.4bn (R361m DSY’s share) to R344m to R4.1bn to R23.3bn Ping An Health Insurance +17% PAHI licence written premium +117% +10% to RMB9.0bn +289% to RMB133m +23% to RMB1.6bn RMB millions RMB millions RMB millions RMB millions H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Lives 0 5 10 15 20 25 30 Jun-19 Dec-19 Jun-20 Dec-20 Jun-21 Dec-21 Jun-22 Dec-22 Jun-23 Dec-23 +34% to 26m PAHI licence lives Millions +34% -- 62 of 72 -- 63 Excellent operating performance Increasing reapplication rates Better persistency Excellent quality 80% 82% 84% 86% 2021 2022 2023 Decreasing COR Strong cash generation - 1 2 3 4 2021 2022 2023 Billions Net cashflow from operating activities (RMB) 100% 95% 95% 91% 2020 2021 2022 2023 Balance sheet strength 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 10,000 2019 2020 2021 2022 2023 Net asset value RMBm as at 31 December RMB8.6bn -- 63 of 72 -- 64 Maintained superior profitability, building a comprehensive business driven by health and wellness services Maintained leading position in the market Developed meaningful health and wellness services -8% -6% -4% -2% 0% 2% 4% 6% 8% 10% PAHI CPIC Health PICC Health 2018 2019 2020 2021 2022 2023 Q3 Net margin Network arrangements with hospitals 1st in China Specialist health insurer in terms of profit margin 2nd largest Specialist health insurer by premium 16th in China In terms of net profit, among all life, P&C and health insurers Providing health insurance products, ranging from basic affordable cover to high-end comprehensive cover, to both the individual market and the corporate market 16 provinces 26m lives 242 outside of China 1 033 China -- 64 of 72 -- 65 Growth platforms -- 65 of 72 -- 66 Discovery grows businesses organically Organic growth model Focused on streamlining New initiatives Growth platforms expected to drive material growth Investment in New % core operating profit 0% 5% 10% 15% 20% 25% H1 2018 H1 2019 H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 + 10% to 15% higher cash flow growth GROWTH PLATFORMS + 5% to 10% higher annual operating profit growth ESTABLISHED EMERGING NEW Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors CPI+5% CPI+30% -10% ESTABLISHED BUSINESSES GROWTH PLATFORMS -- 66 of 72 -- 67 Growth platforms expected to drive material growth FY20 FY21 FY22 FY23 FY24 FY25 FY26 FY27 FY28 Operating profit 10% to 15% higher from Growth platforms Long-term cash flow growth CAGR Established businesses only Established businesses + Growth platforms CPI+[10% to 15%] annual growth Economics of the Growth platforms Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors -- 67 of 72 -- 68 Bringing the Bank to scale and profitability in the near-term − R172m R170m R35mFeb 2024 Operating income Expenses New business acquisition costs Profit / (loss) before tax − = 15% to 20% -10% to 0% -5% to 5% 65% to 75% Medium-term real growth targets Jul-23 Nov-23 Mar-24 Jul-24 Nov-24 Mar-25 Jul-25 Nov-25 Mar-26 Jul-26 Nov-26 Mar-27 Jul'23 projected profit (loss) before NBAC Actual profit (loss) before NBAC Jul'23 projected profit (loss) after NBAC Normalised operating expenses (Rm) NBAC per new client (R) Profit (Loss) before tax Forecast NII +NIR (Rm) J-23 N-23 M-24 J-24 N-24 M-25 J-25 N-25 M-26 J-26 N-26 M-27 0 200 400 600 800 1000 1200 1400 1600 1800 Jul-21 Oct-21 Jan-22 Apr-22 Jul-22 Oct-22 Jan-23 Apr-23 Jul-23 Oct-23 0 20 40 60 80 100 120 140 160 Jul-21 Oct-21 Jan-22 Apr-22 Jul-22 Oct-22 Jan-23 Apr-23 Jul-23 Oct-23 - 20 40 60 80 100 120 140 160 Jul-21 Oct-21 Jan-22 Apr-22 Jul-22 Oct-22 Jan-23 Apr-23 Jul-23 Oct-23 − − 2% CAGR 60% CAGR 1% CAGR R933m R1 097m R185mH1 FY24 − − Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors -- 68 of 72 -- 69 Vitality Network unlocking operational efficiencies Vitality Network global partners Gearing effect due to growing foreign currency revenues and stable ZAR- based expenses +16% USD revenue growth from December 2022 Revenue Strong sales, increasing membership and revenue growth in Asia +8% Expense growth from December 2022 Expenses Flat US dollar cost base, given the cost bias to South African rands +37% USD profit growth from December 2022 Normalised operating profit Robust revenue growth and continued expansion of the profit margin H1FY20 H1FY21 H1FY22 H1FY23 H1FY24 H1FY20 H1FY21 H1FY22 H1FY23 H1FY24 4.4m 8.2m 8.6m 11.5m 15.8m 34.5m 32.0m 33.5m 25.3m 31.2m 35.6m 33.6m 42.2m 43.5m 50.3m Revenue Expenses Profit Operational efficiencies ($m) 3.6x -- 69 of 72 -- 70 Expect Ping An Health Insurance to continue growing strongly Growing lives 0 5 10 15 20 25 30 Jun-19 Dec-19 Jun-20 Dec-20 Jun-21 Dec-21 Jun-22 Dec-22 Jun-23 Dec-23 +34% Excellent quality COR Strong cash generation - 1 2 3 2021 2022 2023 Billions Net cashflow from operating activities H1 2020 H1 2021 H1 2022 H1 2023 H1 2024 Rising written premium1 RMB millions 1 100% of PAHI 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 10,000 2019 2020 2021 2022 2023 as at 31 December 2023 100% 95% 95% 91% 2020 2021 2022 2023 Increasing NAV to 26m y-o-y +14% to R23.3bn 91% R8.1bn RMB Net Asset Value RMBm R22.5bn 3.06x Comprehensive solvency ratio -- 70 of 72 -- 71 Period under review 1 2 3 No material impact on underlying economic value, solvency levels or cash flows, but affected the incidence of profit recognition Strong financial performance with robust operating profit growth, good cash generation and capital resilience A smooth transition to IFRS 17 accounting standard A focused approach to create growth platforms by scaling the Bank, evolving the Vitality Shared-value model, and streamlining New initiatives to embed significant growth potential into the Group Ensuring Discovery SA, Vitality UK, and Vitality Global, and their underlying businesses, are market leaders and performing optimally 4 Normalised operating profit +13% New business +28% FLR 20% Cash conversion 66% + [10% to 15%] higher cash flow growth + [5% to 10%] higher annual operating profit growth GLOBAL +9% +13% +71% Operating profit New business +29% +22% +28% Total Group CSM R38.2bn -- 71 of 72 -- Unaudited Results and cash dividend declaration for the six months ended December 2023 -- 72 of 72 --